Murine Models of Helicobacter (pylori or felis)-associated Gastric Cancer

Curr Protoc Pharmacol. 2015 Jun 1:69:14.34.1-14.34.35. doi: 10.1002/0471141755.ph1434s69.

Abstract

Gastric adenocarcinoma is the fifth most common cancer and third most common cause of cancer-related death in the world. The majority of these cancers develop in genetically susceptible individuals who are chronically infected with the Gram-negative bacterium Helicobacter pylori. Often these individuals have also been exposed to certain environmental factors that increase susceptibility, such as dietary components. Murine models of Helicobacter-induced gastric cancer are valuable tools for investigating the mechanisms responsible for the stepwise pathological changes of chronic atrophic gastritis, intestinal metaplasia, dysplasia and gastric adenocarcinoma. Helicobacter felis colonization greatly accelerates the development of gastric neoplasia in mice, and causes pathologies similar to those observed with Helicobacter pylori-associated gastric carcinogenesis in humans. These mouse models are therefore useful for investigating genetic and environmental factors that may be involved in the pathogenesis and treatment of gastric cancer. Detailed in these protocols are procedures for inducing Helicobacter-associated carcinogenesis in mice as well as the histological analysis and interpretation of gastric pathology in these animals.

Keywords: felis; gastric atrophy; gastric cancer; gastric inflammation; helicobacter; parietal cells; pylori.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / immunology
  • Adenocarcinoma / microbiology*
  • Adenocarcinoma / pathology
  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Carcinogenesis / drug effects
  • Carcinogenesis / immunology
  • Carcinogenesis / metabolism
  • Carcinogenesis / pathology
  • Disease Models, Animal*
  • Gastric Mucosa / drug effects
  • Gastric Mucosa / immunology
  • Gastric Mucosa / microbiology
  • Gastric Mucosa / pathology
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / immunology
  • Helicobacter Infections / microbiology*
  • Helicobacter Infections / pathology
  • Helicobacter felis / drug effects
  • Helicobacter felis / immunology
  • Helicobacter felis / pathogenicity*
  • Helicobacter pylori / drug effects
  • Helicobacter pylori / immunology
  • Helicobacter pylori / pathogenicity*
  • Humans
  • Mice
  • Paraneoplastic Syndromes / drug therapy
  • Paraneoplastic Syndromes / immunology
  • Paraneoplastic Syndromes / microbiology*
  • Paraneoplastic Syndromes / pathology
  • Stomach Neoplasms / drug therapy
  • Stomach Neoplasms / immunology
  • Stomach Neoplasms / microbiology*
  • Stomach Neoplasms / pathology

Substances

  • Anti-Bacterial Agents
  • Antineoplastic Agents